Navigation Links
Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
Date:4/2/2008

$1.5 Billion Annualized Savings Target $500 million in Synergies from OBS Acquisition Rolled into New Target

KENILWORTH, N.J., April 2, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today a major new Productivity Transformation Program (PTP) to reduce and avoid costs and increase productivity to generate a total of $1.5 billion in targeted annual savings and synergies.

The targeted savings represent approximately 10% of the combined company's full year 2007 estimated cost base, including Organon BioSciences (OBS) and manufacturing. The previously announced integration synergy targets of $500 million from the Company's November 2007 acquisition of Organon BioSciences of the Netherlands will be rolled into PTP.

The program responds to dramatically intensifying pressures on the pharmaceutical industry, especially new pressures in the United States, and also to the confusion in the U.S. market around cholesterol management that impacts the products of the Merck/Schering-Plough joint venture, ZETIA and VYTORIN.

While the details of the implementation program are being developed, at least $1.25 billion -or more than 80% - of the planned savings are targeted to be accomplished by the end of 2010, with the balance achieved by 2012, reflecting the longer timelines for implementing such actions effectively and prudently in the global supply chain.

"Savings and productivity improvements will be realized across the company and around the world. No area will be exempt," said Fred Hassan, chairman and CEO. "Our first actions will be to execute reductions in high overhead cost areas, beginning with reductions in higher management levels in the company's headquarters a
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
(Date:8/27/2014)... City, OR (PRWEB) August 27, 2014 ... Report, “Consolidation continues to reshape the look and feel ... nutrition. Consumer demand for higher-quality ingredients will push for ... North American market have experienced strong market growth in ... ethical attributes in their food and cosmetics to fit ...
(Date:8/26/2014)...  NeuroSigma, Inc., a Los Angeles ... today announced that it has filed a registration statement ... Commission relating to a proposed initial public offering of ... offered and the price range for the proposed offering ... will act as the book-running manager for the proposed ...
(Date:8/26/2014)... to the growing case for graphene being bumped ... in the high-tech world by the two-dimensional semiconductors ... researchers led by a scientist with the U.S. ... (Berkeley Lab) has reported the first experimental observation ... The recorded charge transfer time clocked in at ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Competition for graphene 2
... RANCHO CORDOVA, Calif., April 2 /PRNewswire-FirstCall/ -- ... supplier of innovative products and services that process and ... will be the subject of several scientific abstracts to ... 2009 Annual Meeting in San Diego, May 3-6.The abstracts ...
... for Intercell,s IXIARO, the first licensed vaccine against ... Europe -- This final decision follows the positive ... (CHMP) in December 2008VIENNA, April 2 Intercell ... vaccine to prevent Japanese Encephalitis, IXIARO(R), has been ...
... test for detection of methicillin-resistant Staphylococcus aureus for better ... that its new LightCycler(R) test for the detection of ... with the CE Mark, allowing it to be sold ... MRSA Advanced Test is a qualitative in vitro ...
Cached Biology Technology:ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 2ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 3ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 4Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis 2Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis 3Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis 4Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 2Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 3Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 4
(Date:8/27/2014)... 27, 2014. Using functional near infrared spectroscopy (fNIRS), ... patterns between people with multiple sclerosis (MS) and ... in which brain activation was studied using fNIRS ... "Neuroimaging and cognition using functional near infrared spectroscopy ... June 11 by Brain Imaging and Behavior ...
(Date:8/27/2014)... Duke University researchers have identified a gene that could ... encodes a protein in the cell membrane of plants ... plant,s water conservation machinery accordingly. , "It,s similar ... of biology at Duke. , The findings, which ... could make it easier to feed the world,s growing ...
(Date:8/27/2014)... be getting effective doses of the HIV drug maraviroc, ... dosing studies, completed before the drug was licensed in ... that is key to removing maraviroc from the body. ... of the protein including nearly half of African-Americans ... compared to those who lack the protein even when ...
Breaking Biology News(10 mins):Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2Water 'thermostat' could help engineer drought-resistant crops 2Dosage of HIV drug may be ineffective for half of African-Americans 2
... which variation affects intake of caffeine, the most widely consumed ... of investigators from the National Cancer Institute, Harvard School of ... North Carolina at Chapel Hill examined genetic variation across the ... as described in the open-access journal PLoS Genetics . ...
... MEDFORD/SOMERVILLE, Mass. Assistant Professor of Electrical ... an early-career award from the National Science Foundation ... to electricity. Vandervelde, the John A. and ... $400,000, five year award to continue his studies ...
... Fla., April 6, 2011 Ceelox, Inc. (OTCBB: CELO) ... PC Edition which operates on computers running the Windows ... has redesigned their authentication approach to leverage the recent ... Biometric Framework (WBF) provides support for fingerprint biometric devices ...
Cached Biology News:Tufts engineering professor wins NSF Career Award 2Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers 2
... a fully licensed, high throughput, water bath thermal ... to 24 microplates. This equates to 9,216 reactions ... A robotic arm rapidly transfers a basket of ... ramping times that are considerably faster than those ...
... The Brownlee Precision Model 410 is a four-channel ... to amplify small signals from sources which may ... noise. Each channel consists of a high gain/low ... lowpass filter, and an output offset control. A ...
... Pro-OpioMelanoCortin (POMC) has long been a ... precursor to a multiplicity of biologically-active ... -endorphin, Alpha-Melanocyte Stimulating Hormone (a-MSH) and ... well-conserved molecule, being found in most ...
...
Biology Products: